CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- 4 Option exercise Director acquired 6,000 shares (option exercise)
- 4 Option exercise Director acquired 6,000 shares (option exercise)
- 4 Option exercise Director acquired 6,000 shares (option exercise)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- 424B5 Offering Prospectus
- SC 13G/A Stake Amended Statement of Ownership
Page 9 of 38 · 755 filings